173 related articles for article (PubMed ID: 17602160)
1. Initial experience with icodextrin in Indian patients.
Bhowmik D; Khaira A; Mahajan S; Tiwari SC
Perit Dial Int; 2007; 27(4):467-8. PubMed ID: 17602160
[No Abstract] [Full Text] [Related]
2. The kinetics of water transperitoneal transport during long-term peritoneal dialysis performed using icodextrin dialysis fluid.
Olszowska A; Zelichowski G; Waniewski J; Stachowska-Pietka J; Weryński A; Wańkowicz Z
Pol Arch Med Wewn; 2009 May; 119(5):305-10. PubMed ID: 19579812
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
[TBL] [Abstract][Full Text] [Related]
4. Ten years after MIDAS: icodextrin lights and shadows.
Amici G; Da Rin G; Agostini A; Velo S; Bocci C
Contrib Nephrol; 2003; (140):76-81. PubMed ID: 12800346
[No Abstract] [Full Text] [Related]
5. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
[TBL] [Abstract][Full Text] [Related]
6. Icodextrin metabolites in peritoneal dialysis.
García-López E; Lindholm B
Perit Dial Int; 2009; 29(4):370-6. PubMed ID: 19602601
[No Abstract] [Full Text] [Related]
7. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
9. Icodextrin modeling error with PD ADEQUEST, version 2.0.
Amici G; Da Rin G; Bocci C
Perit Dial Int; 2001; 21(5):516-8. PubMed ID: 11757837
[No Abstract] [Full Text] [Related]
10. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients.
Paniagua R; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Orihuela O; Prado-Uribe MD; Alcántara G; Amato D
Perit Dial Int; 2009; 29(4):422-32. PubMed ID: 19602608
[TBL] [Abstract][Full Text] [Related]
11. [Icodextrin in peritoneal dialysis therapy].
Grzegorzewska AE; Antczak-Jedrzejczak D
Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
[TBL] [Abstract][Full Text] [Related]
12. The variability in ultrafiltration achieved with icodextrin, possibly explained.
Venturoli D; Jeloka TK; Ersoy FF; Rippe B; Oreopoulos DG
Perit Dial Int; 2009; 29(4):415-21. PubMed ID: 19602607
[TBL] [Abstract][Full Text] [Related]
13. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal transport with icodextrin solution.
Heimbürger O
Contrib Nephrol; 2006; 150():97-103. PubMed ID: 16720998
[TBL] [Abstract][Full Text] [Related]
15. Potential hazards of polyglucose.
Diaz-Buxo JA; Passlick-Deetjen J; Gotloib L
ASAIO J; 2001; 47(6):602-7. PubMed ID: 11730195
[No Abstract] [Full Text] [Related]
16. High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis.
Yang X; Fang W; Bargman JM; Oreopoulos DG
Perit Dial Int; 2008; 28(1):82-92. PubMed ID: 18178952
[TBL] [Abstract][Full Text] [Related]
17. Icodextrin re-absorption varies with age in children on automated peritoneal dialysis.
Dart A; Feber J; Wong H; Filler G
Pediatr Nephrol; 2005 May; 20(5):683-5. PubMed ID: 15719251
[TBL] [Abstract][Full Text] [Related]
18. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
Qi H; Xu C; Yan H; Ma J
Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
[TBL] [Abstract][Full Text] [Related]
19. Differences in predicting glucose absorption from peritoneal dialysate compared to measured absorption in peritoneal dialysis patients treated by continuous ambulatory peritoneal dialysis and ambulatory peritoneal dialysis cyclers.
Tangwonglert T; Davenport A
Int J Artif Organs; 2020 Jul; 43(7):461-467. PubMed ID: 31960740
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal transport after long-term exposure to Icodextrin in rats.
Frajewicki V; Kushnir D; Wajsbrot V; Kohan R; Shostak A; Gotloib L
Nephron; 2002 Sep; 92(1):174-82. PubMed ID: 12187100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
